Quick Answer
Nuvation Bio Inc. reported Shares Outstanding of 337.84 million shares for fiscal year 2025.
Nuvation Bio Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 337.84M | +0.0% |
| 2024 | 337.84M | +54.2% |
| 2023 | 219.05M | +0.2% |
| 2022 | 218.63M | +0.3% |
| 2021 | 217.95M | +46.2% |
| 2020 | 149.04M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 337.84M | +0.5% | +0.0% |
| June 30, 2025 | 337.84M | +35.9% | +0.0% |
| March 31, 2025 | 337.84M | +54.2% | +0.0% |
| December 31, 2024 | 337.84M | +54.2% | +0.5% |
| September 30, 2024 | 336.25M | +53.6% | +35.2% |
| June 30, 2024 | 248.62M | +13.6% | +13.5% |
| March 31, 2024 | 219.08M | +0.1% | +0.0% |
| December 31, 2023 | 219.05M | +0.2% | +0.0% |
- Nuvation Bio Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Nuvation Bio Inc.’s shares outstanding has grown by 126.7% (from 149.04 million shares to 337.84 million shares).
- The most recent figure is from Nuvation Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: